Crystallization of interleukin-18 for structure-based inhibitor design.

IL-18,Iboctadekin,Interferon gamma-inducing factor,IFN-gamma-inducing factor,Interleukin-1 gamma,IL-1 gamma

YFGKLESKLSVIRNLNDQVLFIDQGNRPLFEDMTDSDCRDNAPRTIFIISMYKDSQRRGMAVTISVACAAASTLSCENKI
ISFKEMNPPDNIKDTKSDIIFFQRRVPGHDNKMQFESSSYEGYFLACEKERDLFKLILKKEDELGDRSIMFTVQNED

35% PEG 3350, 0.1M Tris, 0.1M Sodium Acetate

National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)

cytokine, Interleukin-18, IL-18, surface entropy reduction, immune defense

YFGKLESKLSVIRNLNDQVLFIDQGNRPLFEDMTDSDCRDNAPRTIFIISMYKDSQPRGMAVTISVKCEKISTLSCENKI
ISFKEMNPPDNIKDTKSDIIFFQRSVPGHDNKMQFESSSYEGYFLACEKERDLFKLILKKEDELGDRSIMFTVQNED